HEALTH.2011.1.4-1
HEALTH.2011.1.4-1
7 projects · €40,738,845 total EU contribution (project-level) · 81 participating organizations · 18 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€40,738,845
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (15)
- UK (11)
- BE (7)
- Spain (7)
- France (6)
- Netherlands (6)
- SE (5)
- DK (4)
- HR (4)
- CZ (3)
- Italy (3)
- AT (2)
- CH (2)
- BA (1)
- FI (1)
- MD (1)
- NO (1)
- PL (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- KU Leuven2 projects · BE
- KCH2 projects · UK
- MHH2 projects · DE
- UOXF2 projects · UK
- Leiden University Medical Center1 projects · NL
- ARTTIC1 projects · FR
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1 projects · FR
- EPDA1 projects · BE
- EHB1 projects · BE
- AOUP1 projects · IT
- CARDIOVASCULAR RESEARCH CENTER AALST VZW1 projects · BE
- C3BS1 projects · BE
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
A novel generation of skin substitutes to clinically treat a broad spectrum of severe skin defects EUROSKINGRAFT · 279024 | FP7 | €5,996,018 | €7,875,215 | Details |
Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis REGENER-AR · 279174 | FP7 | €5,925,462 | €7,644,046 | Details |
Development of a novel FGL therapy and translational tests for regenerative treatment of neurological disorders NEUROFGL · 278006 | FP7 | €5,978,735 | €7,807,910 | Details |
Phase II clinical trial of PDGF-BB for the neurological regeneration and recovery in Parkinson´s disease NRT · 279102 | FP7 | €5,962,458 | €8,076,589 | Details |
European clinical study for the application of regenerative heart valves ESPOIR · 278453 | FP7 | €5,200,000 | €6,645,284 | Details |
Novel Bone Morphogenetic Protein-6 Biocompatible Carrier Device for Bone Regeneration OSTEOGROW · 279239 | FP7 | €5,683,089 | €7,368,571 | Details |
The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on all-cause mortality in acute myocardial infarction BAMI · 278967 | FP7 | €5,993,083 | €7,842,161 | Details |